The 505(b)(2) route was always just a hopeful furphy.
The ASCO abstract for DEP-Irinotecan (which is supposedly the most advanced candidate now) stated this in the conclusion:
’warrants further clinical assessment’
And yes, I have noted that the captain of team brown has started the day with three brand new threads. The pump is on. Again. However he’s conveniently ignored all the bad news dump from Wednesday’s webinar.
Laughable.
- Forums
- ASX - By Stock
- DEP Phase 3 trials no certainty
The 505(b)(2) route was always just a hopeful furphy. The ASCO...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.4¢ |
Change
-0.002(1.57%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.4¢ | $2.472K | 25.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21897 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 21301 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 21897 | 0.094 |
1 | 250000 | 0.093 |
1 | 60000 | 0.092 |
4 | 31267 | 0.090 |
2 | 147200 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 21301 | 1 |
0.097 | 39339 | 2 |
0.098 | 65000 | 1 |
0.099 | 48700 | 1 |
0.100 | 111205 | 3 |
Last trade - 10.41am 07/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |